<div class="headers"><div>Figure 2 Clinical remission from Week 44 through Week 92 of treatment among (A) all randomised patients entering the long-term extension and (B) by induction study subgroups. SC, subcutaneous; TNF, tumour necrosis factor; q8w, every 8 weeks; q12w, every 12 weeks</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<tbody>
<tr style='border-top: 2px solid grey;'>
<td style='border-top: 2px solid grey; border-bottom: 2px solid grey; text-align: left;'><p style="" class="">Figure 2 Clinical remission from Week 44 through Week 92 of treatment among (A) all randomised patients entering the long-term extension and (B) by induction study subgroups. SC, subcutaneous; TNF, tumour necrosis factor; q8w, every 8 weeks; q12w, every 12 weeks</p></td>
</tr>
</tbody>
</table>
